BRAINLIFE.ORG




Topics


Glioblastoma | Treatment | Tumor treating fields






Home > Publications > Topics > Glioblastoma > Treatment > Tumor treating fields






Mikic N, Gentilal N, Cao F, Lok E, Wong ET, Ballo M, Glas M, Miranda PC, Thielscher A, Korshoej AR.
Tumor-treating fields dosimetry in glioblastoma: Insights into treatment planning, optimization, and dose-response relationships.
Neurooncol Adv. 2024 Mar 2;6(1):vdae032. doi: 10.1093/noajnl/vdae032. PMID: 38560348. Review. ˍ




*Wang J, Du Q, Chen J, Liu J, Gu Z, Wang X, Zhang A, Gao S, Shao A, Zhang J, Wang Y.
Tumor treating fields in glioblastoma: long-term treatment and high compliance as favorable prognostic factors.
Front Oncol. 2024 Mar 20;14:1345190. doi: 10.3389/fonc.2024.1345190. PMID: 38571508. Observational study. ˍ




Xiang Y, Chen Y, Xu Z, Zhou S, Qin Z, Chen L, Xiao D, Liu S.
Real-world cost-effectiveness analysis: Tumor Treating Fields for newly diagnosed glioblastoma in China.
J Neurooncol. 2024 Apr 2. doi: 10.1007/s11060-024-04662-x. PMID: 38563851. Observational study˰ ˍ




Lan J, Liu Y, Chen J, Liu H, Feng Y, Liu J, Chen L.
Advanced tumor electric fields therapy: A review of innovative research and development and prospect of application in glioblastoma.
CNS Neurosci Ther. 2024 May 7;30(5):e14720. doi: 10.1111/cns.14720. PMID: 38715344. Review. ˍ




Goldlust SA, Singer S, Cappello LA, AlMekkawi AK, Lee KD, Ingenito AC, Lewis BE, Nyirenda T, Azmi H, Kaptain GJ.
Phase 1 study of concomitant tumor treating fields and temozolomide chemoradiation for newly diagnosed glioblastoma.
Neurooncol Adv. 2024 Jul 29;6(1):vdae129. doi: 10.1093/noajnl/vdae129. PMID: 39211521. Interventional study.ˍ




*Pan J, Eskandar T, Ahmed Z, Agrawal DK.
Biophysical and Biological Mechanisms of Tumor Treating Fields in Glioblastoma.
J Cancer Sci Clin Ther. 2024 Aug 19;8(3):265-270. doi: 10.26502/jcsct.5079249. PMID: 39364266. Perspective. ˍ




Biedermann GB, Merrifield K, Lustgarten L.
Case report: Safety of Tumor Treating Fields therapy with an implantable cardiac pacemaker in a patient with glioblastoma.
Front Oncol. 2024 Aug 22;14:1441146. doi: 10.3389/fonc.2024.1441146. PMID: 39239269. Case report. ˍ




Mergen E, Landrock S, Chizzali B.
Tumor Treating Fields (TTFields) Therapy and Lomustine Chemotherapy for the Treatment of Unresectable Progressive Glioblastoma.
Case Rep Oncol. 2024 Sep 23;17(1):1056-1062. doi: 10.1159/000540669. PMID: 39474554. Case report. ˍ




Khagi S, Kotecha R, Gatson NTN, Jeyapalan S, Abdullah HI, Avgeropoulos NG, Batzianouli ET, Giladi M, Lustgarten L, Goldlust SA.
Recent advances in Tumor Treating Fields (TTFields) therapy for glioblastoma.
Oncologist. 2024 Oct 14:oyae227. doi: 10.1093/oncolo/oyae227. PMID: 39401002. Review. ˍ



Tumor treating induced fields

Cai Z, Yang Z, Wang Y, Li Y, Zhao H, Zhao H, Yang X, Wang C, Meng T, Tong X, Zheng H, He Z, Niu C, Yang J, Chen F, Yang Z, Zou Z, Li W.
Tumor treating induced fields: a new treatment option for patients with glioblastoma.
Front Neurol. 2024 Oct 17;15:1413236. doi: 10.3389/fneur.2024.1413236. PMID: 39484048. Laboratory investigation. ˍ